# Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations

> **NCT01306461** · PHASE3 · COMPLETED · sponsor: **Santen Oy** · enrollment: 401 (actual)

## Conditions studied

- Ocular Hypertension
- Open-angle Glaucoma

## Interventions

- **DRUG:** Timolol and Tafluprost
- **DRUG:** Fixed Dose Combination of tafluprost and timolol

## Key facts

- **NCT ID:** NCT01306461
- **Lead sponsor:** Santen Oy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-04
- **Final completion:** 2012-05
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2012-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306461, "Tafluprost-Timolol Fixed Dose Combination Non-Inferiority Study Against Concomitant Administrations". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01306461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*